自然绝经所致血管舒缩症状:基于美国国家卫生与临床优化研究所绝经指南治疗效应的系统评价与网状Meta分析
该系统评价与网状Meta分析检索截至2015年1月13日的英文文献,纳入47项随机对照试验(8326名未切除子宫的自然绝经女性),比较16类治疗对血管舒缩症状的疗效。结果显示,与安慰剂相比,经皮雌二醇联合孕激素缓解血管舒缩症状的概率最高(69.8%;均值比0.23;95%可信区间0.09-0.57),口服雌二醇联合孕激素的排序低于经皮给药但两者无差异。SSRIs或SNRIs不仅无效,且停药几率显著高于安慰剂。
要点
- 经皮雌二醇联合孕激素在缓解血管舒缩症状方面概率最高(69.8%;均值比0.23;95%可信区间0.09-0.57)。
- 口服雌二醇联合孕激素的排序低于经皮给药,但两者对该结局无差异(均值比2.23;95%可信区间0.7-7.1)。
- SSRIs或SNRIs未显示缓解血管舒缩症状的疗效,且停药几率显著高于安慰剂。
核心结论
- 对于未切除子宫的女性,经皮雌二醇联合孕激素是缓解血管舒缩症状最有效的治疗。
研究设计与样本
- 系统评价与网状Meta分析,检索MEDLINE、Embase和Cochrane图书馆截至2015年1月13日的英文文献。
- 纳入47项随机对照试验,共16类治疗,8326名未切除子宫的自然绝经女性,结局包括血管舒缩症状频率(最长26周)、阴道出血和停药。
- 采用贝叶斯网状Meta分析,效应量为均值比和比值比。
主要发现
- 与安慰剂相比,经皮雌二醇联合孕激素成为最有效治疗的概率最高(69.8%;均值比0.23;95%可信区间0.09-0.57)。
- 口服雌二醇联合孕激素的排序低于经皮雌二醇联合孕激素,但两者对该结局无差异(均值比2.23;95%可信区间0.7-7.1)。
- 异黄酮和黑升麻比安慰剂更有效,但未显著优于雌二醇联合孕激素。
- SSRIs或SNRIs未显示缓解血管舒缩症状的疗效,且停药几率显著高于安慰剂。
- 出血相关数据有限,无法得出结论。
局限性
- 出血相关数据有限,无法得出结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vasomotor symptoms (VMSs) are the hallmarks of menopause, occurring in approximately 75% of postmenopausal women in the UK, and are severe in 25%. OBJECTIVES: To identify which treatments are most clinically effective for the relief of VMSs for women in natural menopause without hysterectomy. SEARCH STRATEGY: English publications in MEDLINE, Embase, and The Cochrane Library up to 13 January 2015 were searched. SELECTION CRITERIA: Randomised controlled trials (RCTs) of treatments for women with a uterus for the outcomes of frequency of VMSs (up to 26 weeks), vaginal bleeding, and discontinuation. DATA COLLECTION AND ANALYSIS: Bayesian network meta-analysis (NMA) using mean ratios (MRs) and odd ratios (ORs). MAIN RESULTS: Across the three networks, 47 RCTs of 16 treatment classes (n = 8326 women) were included. When compared with placebo, transdermal estradiol and progestogen (O+P) had the highest probability of being the most effective treatment for VMS relief (69.8%; MR 0.23; 95% credible interval, 95% CrI 0.09-0.57), whereas oral O+P was ranked lower than transdermal O+P, although oral and transdermal O+P were no different for this outcome (MR 2.23; 95% CrI 0.7-7.1). Isoflavones and black cohosh were more effective than placebo, although not significantly better than O+P. Not only were selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) found to be ineffective in relieving VMSs, but they also had significantly higher odds of discontinuation than placebo. Limited data were available for bleeding, therefore no conclusions could be made. CONCLUSION: For women who have not undergone hysterectomy, transdermal O+P was the most effective treatment for VMS relief. TWEETABLE ABSTRACT: Which treatment best relieves menopause flushes? Results from the #NICE guideline network meta-analysis.
引用
- Sarri G, Pedder H, Dias S, et al. Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause. BJOG. 2017. PMID: 28276200. doi:10.1111/1471-0528.14619
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。